What blood tests are used to measure Protein S and Protein C?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Blood Tests for Protein S and Protein C

Protein S and Protein C are measured through specialized coagulation assays using citrated blood samples that require specific collection and processing techniques to ensure accurate results.

Collection and Processing Requirements

  • Venous blood must be collected into tubes containing 3.2% (0.105-0.109 mol/L) trisodium citrate 1
  • Samples require double-centrifugation to ensure platelet count <10.0 × 10^9/L 1
  • Testing should be performed within 4 hours of collection or properly frozen:
    • At -20°C if stored ≤2 weeks
    • At -70°C or below if stored >2 weeks 1
  • Samples should be rapidly thawed at 37°C and thoroughly mixed before testing 1

Types of Protein C Assays

Protein C can be measured using two primary methods:

  1. Functional (Activity) Assays:

    • Amidolytic (Chromogenic) Assay: Recommended as the initial test for protein C deficiency 2
    • Measures the ability of activated protein C to cleave a chromogenic substrate
    • More reliable than clotting-based assays
  2. Antigenic (Immunological) Assays:

    • Used for subclassification of protein C deficiency type 2
    • Measures the total amount of protein C present regardless of function

Types of Protein S Assays

Protein S exists in two forms: free (active) and bound to C4b-binding protein. Testing includes:

  1. Functional Assays:

    • Measures protein S's ability to act as a cofactor for activated protein C 3
    • Based on factor Va inactivation by activated protein C 3
    • Can detect functional abnormalities not identified by antigenic assays
  2. Antigenic Assays:

    • Total Protein S: Measured by immunoelectrophoresis 3
    • Free Protein S: Can be measured by:
      • PEG precipitation followed by immunoassay (traditional method) 4
      • Direct one-step ELISA using monoclonal antibodies specific for free protein S (newer method) 4

Testing Considerations

  • Timing: Tests should be performed at least 3 months after acute thrombotic events and at least 2 weeks after discontinuing oral anticoagulants 5
  • Confirmation: Low protein C or S levels should be confirmed with a subsequent assay on a new specimen 2
  • Interferences:
    • Icterus, hemolysis, and lipemia can interfere with results 1
    • Direct oral anticoagulants (DOACs) can interfere with both protein C and S assays 5
    • Vitamin K antagonists significantly affect results 5

Clinical Application

  • These tests are part of a comprehensive thrombophilia panel for patients with:
    • Venous thrombosis under age 50
    • Recurrent venous thrombosis
    • Thrombosis in unusual sites
    • Strong family history of thrombotic disease 5

Interpretation Pitfalls

  • Protein C and S levels can be decreased during:

    • Acute thrombotic events
    • Pregnancy
    • Liver disease
    • DIC
    • Vitamin K deficiency
    • Anticoagulant therapy 5
  • False results may occur if testing is performed too soon after a thrombotic event or while on anticoagulation therapy 5

For accurate diagnosis of deficiencies, testing should be repeated when the patient is not on anticoagulant therapy and not experiencing an acute thrombotic event 5, 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hereditary Thrombophilia Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.